Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioblastoma × Capecitabine × Clear all

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 31 Breast Neoplasms 28 Pancreatic Neoplasms 20 Neoplasm Metastasis 16 Rectal Neoplasms 14 Stomach Neoplasms 13 Neoplasms 12 Esophageal Neoplasms 8 Triple Negative Breast Neoplasms 6 Colorectal Cancer Metastatic 6 Colonic Neoplasms 6 Brain Neoplasms 4 Adenocarcinoma 4 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Bile Duct Neoplasms 3 Advanced Solid Tumors 3 Squamous Cell Carcinoma of Head and Neck 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Non-Hodgkin 2 Liver Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Biliary Tract Neoplasms 2 Adenocarcinoma Of Esophagus 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1

Interventions

Temozolomide 65 Radiotherapy 26 Bevacizumab 23 Carboplatin 12 Radiation 11 pembrolizumab 10 Irinotecan 7 Carmustine 7 Surgical Procedures, Operative 6 Radiosurgery 6 Erlotinib Hydrochloride 6 Nivolumab 5 Everolimus 5 temsirolimus 4 atezolizumab 4 Vorinostat 4 Radiotherapy, Intensity-Modulated 4 Lomustine 4 Aminolevulinic Acid 4 tipifarnib 3 fludarabine 3 Sirolimus 3 Radiotherapy, Conformal 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 IL13-PE38 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 Drug Therapy 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03213002 2025-04-09

CAPTEM

Northwell Health

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡